Average Co-Inventor Count = 4.72
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (23 from 3,681 patents)
2. E. R. Squibb Sons, Inc. (1 from 1,624 patents)
3. Astrazeneca Ab (1,500 patents)
24 patents:
1. 8299054 - Cyclic 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
2. 8278462 - Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
3. 8143403 - CGRP receptor antagonists
4. 7705033 - Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
5. 7655689 - Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
6. 7611880 - Enzymatic ammonolysis process for the preparation of intermediates for DPP IV inhibitors
7. 7517904 - Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
8. 7420079 - Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
9. 7393667 - Stereoselective reduction process for the preparation of pyrrolotriazine compounds
10. 7223573 - Enzymatic ammonolysis process for the preparation of intermediates for DPP IV inhibitors
11. 7141578 - Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
12. 6953679 - Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
13. 6486331 - Substituted alkylketo compounds and process
14. 6468781 - Stereoselective reductive amination of ketones
15. 6433198 - Preparation of 6-&agr;-hydroxy-7-deoxytaxanes using nocardioides luteus or a hydroxylase isolated therefrom